Measurement of peroxiredoxin-4 serum levels in rat tissue and its use as a potential marker for hepatic disease

Ito,Ritsu; Takahashi,Motoko; Ihara,Hideyuki; Tsukamoto,Hiroki; Fujii,Junichi; Ikeda,Yoshitaka

doi:10.3892/mmr.2012.935

Measurement of peroxiredoxin-4 serum levels in rat tissue and its use as a potential marker for hepatic disease

Authors:
- Ritsu Ito
- Motoko Takahashi
- Hideyuki Ihara
- Hiroki Tsukamoto
- Junichi Fujii
- Yoshitaka Ikeda
View Affiliations

Affiliations: Division of Molecular Cell Biology, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga 849‑8501, Japan, Department of Biochemistry, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo 060-8556, Japan, Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Yamagata University, Yamagata 990-9585, Japan
Published online on: June 6, 2012 https://doi.org/10.3892/mmr.2012.935
Pages: 379-384

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Peroxiredoxin (Prx)-4, a secretable endoplasmic reticulum (ER)-resident isoform of the mammalian Prx family, functions as a thioredoxin-dependent peroxidase. It is acknowledged that Prx-4 plays a role in the detoxification of hydrogen peroxide, and potentially other peroxides, which may be generated during the oxidative folding of proteins and oxidative stress in the ER. The present study was undertaken in order to specifically quantify the tissue levels of Prx-4. To accomplish this, an enzyme-linked immunosorbent assay was developed using a specific polyclonal antibody produced by immunizing a rabbit with native recombinant rat Prx-4 protein. The assay was used to detect Prx-4 in the range of 0.1 and 10 ng/ml, and to investigate tissue distribution in rats. Using this immunoassay, we found that the serum levels of Prx-4 were substantially lower in asymptomatic Long-Evans Cinnamon rats, a rat model of Wilson's disease, compared to normal rats. In addition, the treatment of rat hepatoma cells with N-acetylcysteine led to a significant increase in the release of Prx-4 protein into the medium; thus, it appears likely that the secretion of Prx-4 is associated with the redox state within cells. These results suggest that serum Prx-4 has potential for use as a biomarker for hepatic oxidative stress.

View Figures

View References

1	Halliwell B and Gutteridge JMC: Free Radicals in Biology and Medicine. 4th edition. Oxford University Press; Oxford, United Kingdom: 2007
2	Fridovich I: Oxygen toxicity: a radical explanation. J Exp Biol. 201:1203–1209. 1998.PubMed/NCBI
3	Papa S and Skulachev VP: Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem. 174:305–319. 1997. View Article : Google Scholar : PubMed/NCBI
4	Rhee SG, Kang SW, Chang TS, Jeong W and Kim K: Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 52:35–41. 2001. View Article : Google Scholar : PubMed/NCBI
5	Rhee SG, Yang KS, Kang SW, Woo HA and Chang TS: Controlled elimination of intracellular H₂O₂: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid Redox Signal. 7:619–626. 2005.PubMed/NCBI
6	Rhee SG, Chae HZ and Kim K: Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 38:1543–5152. 2005. View Article : Google Scholar : PubMed/NCBI
7	Fujii J and Ikeda Y: Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 7:123–130. 2002. View Article : Google Scholar : PubMed/NCBI
8	Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ and Shao ZM: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res. 9:R762007. View Article : Google Scholar : PubMed/NCBI
9	Iraqui I, Faye G, Ragu S, Masurel-Heneman A, Kolodner RD and Huang ME: Human peroxiredoxin PrxI is an orthologue of yeast Tsa1, capable of suppressing genome instability in Saccharomyces cerevisiae. Cancer Res. 68:1055–1063. 2008. View Article : Google Scholar : PubMed/NCBI
10	Song IS, Kim SU, Oh NS, Kim J, Yu DY, Huang SM, Kim JM, Lee DS and Kim NS: Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells. Carcinogenesis. 30:1106–1114. 2009. View Article : Google Scholar : PubMed/NCBI
11	Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH and Van Etten RA: Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 424:561–565. 2003. View Article : Google Scholar : PubMed/NCBI
12	Fang J, Nakamura T, Cho DH, Gu Z and Lipton SA: S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson’s disease. Proc Natl Acad Sci USA. 104:18742–18747. 2007.PubMed/NCBI
13	Cha MK, Suh KH and Kim IH: Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res. 28:932009. View Article : Google Scholar : PubMed/NCBI
14	Karihtala P, Mantyniemi A, Kang SW, Kinnula VL and Soini Y: Peroxiredoxins in breast carcinoma. Clin Cancer Res. 9:3418–3424. 2003.PubMed/NCBI
15	Quan C, Cha EJ, Lee HL, Han KH, Lee KM and Kim WJ: Enhanced expression of peroxiredoxin I and VI correlates with development, recurrence and progression of human bladder cancer. J Urol. 175:1512–1516. 2006. View Article : Google Scholar : PubMed/NCBI
16	Lehtonen ST, Svensk AM, Soini Y, Paakko P, Hirvikoski P, Kang SW, Saily M and Kinnula VL: Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer. 111:514–521. 2004. View Article : Google Scholar : PubMed/NCBI
17	Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H and Yoshida H: Peroxiredoxin I expression in oral cancer: a potential new tumor marker. Cancer Lett. 156:27–35. 2000. View Article : Google Scholar : PubMed/NCBI
18	Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH and Yoo YJ: Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun. 289:507–512. 2001. View Article : Google Scholar : PubMed/NCBI
19	Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS and Woo HA: Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr Opin Cell Biol. 17:183–189. 2005. View Article : Google Scholar : PubMed/NCBI
20	Rhee SG: Cell signaling. H₂O₂, a necessary evil for cell signaling. Science. 312:1882–1883. 2006.PubMed/NCBI
21	Okado-Matsumoto A, Matsumoto A, Fujii J and Taniguchi N: Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem. 127:493–501. 2000. View Article : Google Scholar : PubMed/NCBI
22	Tavender TJ, Sheppard AM and Bulleid NJ: Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochem J. 411:191–199. 2008. View Article : Google Scholar : PubMed/NCBI
23	Schulte J, Struck J, Bergmann A and Kohrle J: Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta. 411:1258–1263. 2010. View Article : Google Scholar : PubMed/NCBI
24	Tavender TJ and Bulleid NJ: Peroxiredoxin IV protects cells from oxidative stress by removing H₂O₂ produced during disulphide formation. J Cell Sci. 123:2672–2679. 2010. View Article : Google Scholar : PubMed/NCBI
25	Bertolotti M, Yim SH, Garcia-Manteiga JM, Masciarelli S, Kim YJ, Kang MH, Iuchi Y, Fujii J, Vene R, Rubartelli A, Rhee SG and Sitia R: B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal. 13:1133–1144. 2010. View Article : Google Scholar : PubMed/NCBI
26	Ikeda Y, Ito R, Ihara H, Okada T and Fujii J: Expression of N-terminally truncated forms of rat peroxiredoxin-4 in insect cells. Protein Expr Purif. 72:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
27	Matsumoto A, Okado A, Fujii T, Fujii J, Egashira M, Niikawa N and Taniguchi N: Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett. 443:246–250. 1999. View Article : Google Scholar : PubMed/NCBI
28	Yoshida MC, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K and Mori M: New mutation causing hereditary hepatitis in the laboratory rat. J Hered. 78:361–365. 1987.PubMed/NCBI
29	Li Y, Togashi Y, Sato S, Emoto T, Kang JH, Takeichi N, Kobayashi H, Kojima Y, Une Y and Uchino J: Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson’s disease. J Clin Invest. 87:1858–1861. 1991.PubMed/NCBI
30	Wu J, Forbes JR, Chen HS and Cox DW: The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat Genet. 7:541–545. 1994. View Article : Google Scholar : PubMed/NCBI
31	Masuda R, Yoshida MC, Sasaki M, Dempo K and Mori M: High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res. 79:828–835. 1988. View Article : Google Scholar : PubMed/NCBI
32	Marquez-Quinones A, Cipak A, Zarkovic K, Fattel-Fazenda S, Villa-Trevino S, Waeg G, Zarkovic N and Gueraud F: HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats. Free Radic Res. 44:119–127. 2010. View Article : Google Scholar : PubMed/NCBI
33	Samuele A, Mangiagalli A, Armentero MT, Fancellu R, Bazzini E, Vairetti M, Ferrigno A, Richelmi P, Nappi G and Blandini F: Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson’s disease. Biochim Biophys Acta. 1741:325–330. 2005.PubMed/NCBI
34	Madhani M, Barchowsky A, Klei L, Ross CR, Jackson SK, Swartz HM and James PE: Antibacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim Biophys Acta. 1588:232–240. 2002. View Article : Google Scholar : PubMed/NCBI
35	Sato H, Shiiya A, Kimata M, Maebara K, Tamba M, Sakakura Y, Makino N, Sugiyama F, Yagami K, Moriguchi T, Takahashi S and Bannai S: Redox imbalance in cystine/glutamate transporter-deficient mice. J Biol Chem. 280:37423–37429. 2005. View Article : Google Scholar : PubMed/NCBI
36	Khan N, Williams BB, Hou H, Li H and Swartz HM: Repetitive tissue pO₂ measurements by electron paramagnetic resonance oximetry: current status and future potential for experimental and clinical studies. Antioxid Redox Signal. 9:1169–1182. 2007.
37	Nagaoka Y, Iuchi Y, Ikeda Y and Fujii J: Glutathione reductase is expressed at high levels in pancreatic islet cells. Redox Rep. 9:321–324. 2004. View Article : Google Scholar : PubMed/NCBI
38	Fujii T, Fujii J and Taniguchi N: Augmented expression of peroxiredoxin VI in rat lung and kidney after birth implies an antioxidative role. Eur J Biochem. 268:218–225. 2001. View Article : Google Scholar : PubMed/NCBI